State Street’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

State Street’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,729	Closed	-$5K	–	4935
2022 Q3	$5K	Hold	20,729	–	–	﹤0.01%	4918
2022 Q2	$9K	Hold	20,729	–	–	﹤0.01%	4929
2022 Q1	$14K	Buy	20,729 +829	+4%	+$800	﹤0.01%	4903
2021 Q4	$33K	Hold	19,900	–	–	﹤0.01%	4752
2021 Q3	$83K	Buy	+19,900	New	+$102K	﹤0.01%	4588
2021 Q2	–	Sell	-40,754	Closed	-$344K	–	4506
2021 Q1	$344K	Buy	+40,754	New	+$426K	﹤0.01%	3778

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

State Street's SCPS Position: Q4 2022 in Review

State Street sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 20,729 shares — an estimated $5K sold.

State Street first reported a position in SCPS in Q1 2021 and held it in 6 quarters. The position peaked at $344K in Q1 2021. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

State Street reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
State Street sold 20,729 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $5K.
State Street first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 6 quarters.
State Street's Scopus BioPharma Inc. Common Stock position peaked at $344K in Q1 2021.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.